Clinical trial
Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
NCT00264888 · PTC Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00264888 |
|---|---|
| Title | Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy |
| Official title | A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy |
| Lead sponsor | PTC Therapeutics, Industry |
| Collaborators | Muscular Dystrophy Association |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Duchenne Muscular Dystrophy |
| Intervention type | Drug |
| Interventions | PTC124 |
| Enrollment | 38 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Dec 13, 2005 |
| Last update posted | Jan 14, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: